Clinical Trial Update: NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction

View source ↗

Summary

A clinical trial update suggests neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) may serve as cost-effective preliminary prognostic markers in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Snippet

Sponsor: Sohag University | Conditions: STEMI | Status: RECRUITING